Curis stock split

Curis Announces 1-for-5 Reverse Stock Split - Citybizlist

Curis Announces Effectiveness of 1-for-5 Reverse Stock Split The new CUSIP number for Curis's common stock following the reverse stock split is 231269 200. The reverse stock split affects all issued and outstanding shares of Curis's common stock, as well as Curis, Inc. (CRIS) Stock Forum & Discussion - Yahoo Finance Find the latest Curis, Inc. (CRIS) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Curis Announces 1-for-5 Reverse Stock Split - MarketWatch May 22, 2018 · Curis will affect the reverse stock split by filing an amendment to its certificate of incorporation reflecting the approved split ratio, and Curis anticipates that …

The new CUSIP number for Curis's common stock following the reverse stock split is 231269 200. The reverse stock split affects all issued and outstanding shares of Curis's common stock, as well as

The reverse stock split will affect all holders of common stock uniformly and will not alter any stockholder's percentage ownership interest in Curis, except to the extent that the reverse stock Home - Curis, Inc About Curis is a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. We currently have three drug candidates in development: Fimepinostat (formerly known as CUDC-907), an orally available, small molecule inhibitor of HDAC and PI3K enzymes being investigated in a Phase 2 clinical trial in patients with … Curis Announces Effectiveness of 1-for-5 Reverse Stock Split The new CUSIP number for Curis's common stock following the reverse stock split is 231269 200. The reverse stock split affects all issued and outstanding shares of Curis's common stock, as well as Curis, Inc. (CRIS) Stock Forum & Discussion - Yahoo Finance Find the latest Curis, Inc. (CRIS) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Curis Announces Effectiveness of 1-for-5 Reverse Stock Split

May 29, 2018 · Curis Announces Effectiveness of 1-for-5 Reverse Stock Split PR Newswire LEXINGTON, Mass., May 29, 2018 LEXINGTON, Mass., May 29, 2018 /PRNewswire/ CRIS - Curis, Inc. Summary, Stock Quote and News | Benzinga Jan 01, 2010 · Curis, Inc. (NASDAQ: CRIS) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. CRIS Price Target and Analyst Ratings (Curis) | MarketBeat

Curis, Inc. - CRIS - Get Stock Split History

Curis, Inc. (NASDAQ:CRIS), Shortly after that, the company enacted a 1-for-5 reverse stock split in order to bring its share price above $1. That's never a good sign. Curis (CRIS) Announces Effectiveness of 1-for-5 Reverse ... The new CUSIP number for Curis's common stock following the reverse stock split is 231269 200. The reverse stock split affects all issued and outstanding shares of Curis's common stock, as well as CUR Split History Neuralstem (CUR) has 2 splits in our CUR split history database. The first split for CUR took place on January 09, 2017. This was a 1 for 13 reverse split, meaning for each 13 shares of CUR owned pre-split, the shareholder now owned 1 share.

Curis, Inc. Common Stock (CRIS) Institutional Holdings ...

CRIS Stock Price, Forecast & News (Curis) | MarketBeat Curis's stock reverse split on the morning of Wednesday, May 30th 2018. The 1-5 reverse split was announced on Tuesday, May 22nd 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 29th 2018. An investor that had 100 shares of Curis stock prior to the reverse split would have 20 shares after the Curis Announces 1-for-5 Reverse Stock Split The reverse stock split will affect all holders of common stock uniformly and will not alter any stockholder's percentage ownership interest in Curis, except to the extent that the reverse stock Home - Curis, Inc About Curis is a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. We currently have three drug candidates in development: Fimepinostat (formerly known as CUDC-907), an orally available, small molecule inhibitor of HDAC and PI3K enzymes being investigated in a Phase 2 clinical trial in patients with … Curis Announces Effectiveness of 1-for-5 Reverse Stock Split

Curis (CRIS) Stock: Climbing On Asset Sale | CNA Finance Mar 25, 2019 · Curis, Inc. (NASDAQ: CRIS) is rocketing early on in the trading session this morning, and for good reason.The company announced that it entered into … CRIS - Curis Stock Profile - Barchart.com Company profile for Curis Inc (CRIS) including business summary, key statistics, ratios, sector. A stock's Profile page contains general information about the stock, such as Ticker Symbol, Exchange traded on, Company Contact Address/Phone, CEO/President, and Company Description. Most Recent Split: The share split recorded and the date CRIS Historical Stock Prices Curis (CRIS) has the following price history information. Looking back at CRIS historical stock prices for the last five trading days, on January 27, 2020, CRIS opened at $1.63, traded as high as $1.66 and as low as $1.61, and closed at $1.61. Trading volume was a total of 65.00K shares.